Antitumor mechanisms of OncoTherad nano- immunotherapy involving toll-like 4 recep...
New Therapeutic Approaches for Non-Muscle Invasive Bladder Cancer (NMIBC): Intrave...
Therapeutic and toxicological effects of OncoTherad (MRB-CFI-1) immunotherapy in p...
Intravesical interaction of Salmonella enterica typhimurium and p -MAPA in bladder...
Association of immunotherapy with OncoTherad® (MRB-CFI-1) and erythropoietin in th...
Emerging Therapeutic Approach for Non-Muscle Invasive Bladder Cancer through Monoa...
Metabolic Reprogramming in Non-Muscle Invasive Bladder Cancer: Impact of OncoThera...